OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
March 02, 2021
Bio/pharma works hard today to change the calendar to tomorrow.
More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.
February 02, 2021
More work is needed to educate businesses on the value of innovation and the availability of funding.
COVID-19 vaccine supplies are breaking news headlines, in both ‘good’ and ‘not so good’ ways.
Viewpoint: Mike Hennessy, Sr., founder and chairman of MJH Life Sciences, commends the leadership of the pharmaceutical industry in combatting the COVID-19 pandemic.
A complicated vaccination rollout and mixed messages may derail the pandemic endgame.
January 02, 2021
The outlook for the European pharma industry is appearing to be favourable overall.
November 02, 2020
Industry wants clarification on compliance following the end of the Brexit transition period.
Resolving drug shortages starts with identifying the source of the problem.
October 15, 2020
The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.